The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Paul A. Marks sits on this spectrum.
This scientist: 270 publications — 72nd percentile
72% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Paul A. Marks sits on this spectrum.
This scientist: 92 D-Index — 89th percentile
89% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Paul A. Marks was affiliated with Columbia University in the United States. Their research spanned several interrelated scientific fields, primarily focusing on Medicine, Biochemistry, Genetics and Molecular Biology, and Engineering. The work contributed to both foundational and applied aspects of biomedical sciences and related technologies.
Their publications addressed a range of topics within the biomedical research landscape. Key areas of focus included:
Major subfields in their work included Biomedical Engineering, Molecular Biology, Surgery, Genetics, and Rheumatology.
Their scholarly output included papers published in venues such as bioRxiv (Cold Spring Harbor Laboratory) and the SSRN Electronic Journal. Notable recent publications were:
Frequent coauthors included Ane Albillos Sanchez, Paula Casademunt, Adrián Seijas-Gamardo, Lorenzo Moroni, and Carlos Mota, each collaborating on multiple publications.
Throughout their career, Paul A. Marks received several recognitions including being named a Member of the National Academy of Sciences (1973) and a Fellow of the American Association for the Advancement of Science (AAAS) in 1982. In 1991, they were awarded the US President's National Medal of Science for contributions to hematology, specifically for defining the genetic basis for G6PD deficiency and thalassemia and for discovering an approach to control cancer cell proliferation with new inducers of differentiation.
Paul A. Marks;Richard A. Rifkind;Victoria M. Richon;Ronald Breslow
Michael S. Finnin;Jill R. Donigian;Alona Cohen;Victoria M. Richon
Victoria M. Richon;Stephane Emiliani;Eric Verdin;Yael Webb
E. Hockly;V.M. Richon;B. Woodman;D.L. Smith
Constantine S. Mitsiades;Nicholas S. Mitsiades;Ciaran J. McMullan;Vassiliki Poulaki
Lisa M. Butler;Xianbo Zhou;Wei-Sheng Xu;Howard I. Scher
Melissa J. Peart;Gordon K. Smyth;Ryan K. van Laar;David D. Bowtell
V M Richon;Y Webb;R Merger;T Sheppard
Roberta C. Reuben;Richard L. Wife;Ronald Breslow;Richard A. Rifkind
Pamela N. Munster;Tiffany Troso-Sandoval;Neal Rosen;Richard Rifkind
Li-Zhen He;Thomas Tolentino;Peter Grayson;Sue Zhong
Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Ciaran McMullan
Xianbo Zhou;Paul A. Marks;Richard A. Rifkind;Victoria M. Richon
Paul A. Marks;Alfred Gellhorn;Chev Kidson
Ronald Breslow;Paul A. Marks;Richard A. Rifkind;Branko Jursic
H Yamasaki;E Fibach;U Nudel;I B Weinstein
Masao Tanaka;Joseph Levy;Masaaki Terada;Ronald Breslow
Paul A. Marks;Julia Banks
Mandana Namdar;Gisela Perez;Lang Ngo;Paul A. Marks
Eitan Fibach;Roberta C. Reuben;Richard A. Rifkind;Paul A. Marks
If you think any of the details on this page are incorrect, let us know.
